Navigation Links
Pharmalink AB Gains Exclusive Licence to Archimedes Pharma's TARGIT® Technology for Nefecon® (PL-56) Program
Date:12/13/2011

idneys through suppression of the gut immune system. It is delivered using the proprietary TARGIT drug delivery technology which enables the localized delivery of drugs to the lower small intestine or colonic regions of the gut. The concept underlying Nefecon is a patented invention by Professors Bengt Fellström and Roger Hällgren at Uppsala University (Sweden).

About Pharmalink

Pharmalink is a Swedish specialty pharma company developing high value products for niche indications. Pharmalink draws on its extensive experience of pharmaceutical product development and the excellence of medical science in Sweden to identify and progress products that address significant unmet medical needs. Pharmalink has introduced more than 15 pharmaceutical products to the market. Using a repurposing and reformulation strategy, Pharmalink minimizes the risk of product development. The Company's strategy is to apply its expertise to drive drug development and commercialise with partners. Pharmalink currently has two clinical phase projects under development, Nefecon® and BusulipoTM, and is actively in-licensing promising new projects to add to its pipeline. Visit http://www.pharmalink.se for further information.

About Archimedes Pharma

Archimedes Pharma is an international specialty pharmaceutical company providing novel and advanced treatments to address unmet needs for people living with serious or life-threatening chronic and debilitating illnesses. Archimedes Pharma markets a diverse portfolio of specialty products and has operations in the U.S. and throughout Europe. For more information, please visit: http://www.ArchimedesPharma.com.

TARGIT is a registered trademark of Archimedes Development Limited, a subsidiary of Archimedes Pharma Ltd.

For further information, please contact:

Pharmalink AB:
Johan Häggblad, M
'/>"/>

SOURCE Pharmalink AB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharmalink AB Strengthens its Board of Directors and Signals a Strategic Step Towards Late Phase Product Development
2. Pharmalink AB Completes Phase II Clinical Study With Renal Disease Drug Nefecon(R)
3. Pharmalink AB Closes Deal With Grifols SA for the Acquisition of the Xepol(R) Programme for the Treatment of Post-Polio Syndrome
4. PSKW Expands Its Lawsuit Against McKesson to Seek Assignment of McKessons Patent Application
5. Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule
6. Massachusetts Company May Have Silver Bullet In Vitamin D Fight Against Disease
7. UCF professor develops vaccine to protect against black plague bioterror attack
8. New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS
9. Integrated BioTherapeutics Awarded NIAID Contract For Up to $65 Million for Development of a Vaccine against Ebola and Marburg Viruses
10. The Plasmodium vivax genome provides new routes and challenges in the global fight against malaria
11. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Park Systems , world-leader in atomic ... vacuum AFM system in the market that meets the ... Park NX-Hivac is ideal for academic and industrial customers ... doped semiconductor processing where more highly sophisticated failure analysis ... scanning spreading resistance microscopy (SSRM) of Park NX-Hivac enables ...
(Date:5/5/2015)... RURO, Inc., a leading LIMS, RFID and sample ... major content upgrade to its bestselling, Commercial Off-The-Shelf (COTS) ... a significant advancement of FreezerPro® system , ... also simplifying , New FreezerPro® VM ... Download available immediately for free to “Gold” support subscribers ...
(Date:5/5/2015)... May 05, 2015 VetStem Biopharma, ... Animal Health, Jeffrey Schaffer, DVM, as Director of ... 15 years of experience in the veterinary regenerative ... addition to our veterinarian lead organization”. Dr. ... “Dr. Schaffer will be responsible for all technical ...
(Date:5/5/2015)... May 05, 2015 The Academy of ... of Indiana, led by Indiana Gov. Mike Pence, has ... AMA Foundation will host a Family Fest and aviation ... proceeds will benefit the Wounded Warrior Project. , National ... of Model Aeronautics—the country’s foremost organization for model aviation—to ...
Breaking Biology Technology:Park Systems Introduces Park NX-Hivac, a High Vacuum SSRM AFM System for Optimal Results in Semiconductor Manufacturing Failure Analysis 2Park Systems Introduces Park NX-Hivac, a High Vacuum SSRM AFM System for Optimal Results in Semiconductor Manufacturing Failure Analysis 3RURO Releases version 7 of FreezerPro® software 2Leading Regenerative Veterinary Medicine Company, VetStem Biopharma announces the addition of Dr Jeffrey Schaffer as the Director of Veterinary Professional Services. 2State of Indiana proclaims August 15 as Model Aviation Day 2
... Hadasit Bio-Holdings, Ltd. - (OTCBB: HADSY), a publicly traded ... developed and owned by the Hadassah University Hospital, Israel,s ... its portfolio companies have received grant approvals from the ... Ministry of Industry, Trade and Labor. ...
... Dec. 1, 2011 Generex Biotechnology Corporation ( www.generex.com ... status of the clinical and regulatory program for ... product. Work has been completed on ... revising all of the extant Generex Oral-lyn™ Clinical ...
... Corporation, a company enabling a new generation of molecular ... Mo lecule A rray (SiMoA™) technology, announced ... $250,155 contract from the Department of Homeland Security (DHS) ... of botulinum toxin (BoNT) within complex environmental samples. In collaboration ...
Cached Biology Technology:Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies 2Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program 2Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program 3Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program 4Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin 2Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin 3
(Date:4/1/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces the second shipment ... underway to early access pre-order customers. ... retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, Stop ... accepted at all outlets and very easy to use. ...
(Date:3/31/2015)...   Guidepoint , a leading global research services ... Management TRACKER, part of the Guidepoint TRACKER ... medical device and therapeutics markets. The Post-Surgical Pain Management ... market share, and adoption rates across three major modalities ... The Post-Surgical Pain Management TRACKER will provide ...
(Date:3/24/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ... Iris Recognition Market 2015-2019" report to their offering. ... market to grow at a CAGR of 23.5 percent ... the present scenario and the growth prospects of the ... calculate the market size, the report considers the revenue ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... the evolutionary past, because they represent an early offshoot ... Despite their inconspicuous appearance, lampreys have a sophisticated immune ... resemble our B and T cells, researchers have discovered. ... the Max Planck Institute of Immunology and Epigenetics in ...
... 12, 2013  The EMMES Corporation today announced that Dr. ... promoted to president and chief executive officer.  Lindblad replaces ... named past president. (Photo: http://photos.prnewswire.com/prnh/20130812/PH57809 ... continue the legacy that Don and I built at ...
... acute respiratory syndrome (SARS) Middle East respiratory syndrome coronavirus ... people think these trends are on the decline. , ... combat this epidemic are being spearheaded by a team ... Monica Borucki, a principal investigator (PI) in LLNL,s Biosciences ...
Cached Biology News:Lampreys provide hints to ancient immune cells 2Dr. Anne Lindblad Promoted To President/CEO Of The EMMES Corporation 2LLNL scientists make new discoveries in the transmission of viruses between animals and humans 2
... choice of Printing Surface (3 glass slides coated with ... 1 silicon wafer coated with 1000 Angstroms of Gold ... and PDMS Stamps (3 PDMS micropatterned stamps with series ... x 10 mm or 200 um x 10 mm ...
LTBP-1 (E-20)...
Anti-human CD48/BLAST-1, clone MEM102, Monoclonal Antibody...
Recognizes Kir4.1. The epitope does not share homology with any other known proteins.,SPECIES REACTIVITIES: The antibody is also expected to work with mouse and human due to sequence homology. Oth...
Biology Products: